PM&R Meeting Abstracts

Official abstracts site for the AAPM&R Annual Assembly and the PM&R Journal.

MENU 
  • Home
  • Meetings Archive
    • AAPM&R Annual Assembly 2022
    • AAPM&R Annual Assembly 2021
    • AAPM&R Annual Assembly 2020
    • AAPM&R Annual Assembly 2019
  • Resources
  • Advanced Search

Identifying Risk Factors for Female Athlete Triad and a Male Equivalent in Ultramarathon Runners

Emily K. Miller, MD (Stanford University PM&R Program, Palo Alto, CA, United States); Emily Kraus; Tracy B. Hoeg, MD, PhD; Marko Bodor; Michael Fredericson, MD; Kristin Sainani, PhD

Meeting: AAPM&R Annual Assembly 2019

Session Information

Date: Thursday, November 14, 2019

Session Title: Musculoskeletal and Sports Medicine Research Report

Session Time: 12:30pm-2:00pm

Location: Research Hub - Kiosk 8

Disclosures: Emily K. Miller, MD: Nothing to disclose

Objective: This study explores the prevalence of Female Athlete Triad (Triad) risk in ultramarathon runners using the female athlete cumulative risk assessment tool and a piloted male equivalent.

Design: Cohort study

Setting: The Western States 100-mile race

Participants: 61 (20 female, 41 male) runners

Interventions: Participants completed a questionnaire, which included history of disordered eating, bone stress injury (BSI), and menstrual irregularity. They completed dual-energy x-ray absorptiometry (DXA) to measure bone mineral density (BMD) of the lumbar spine, femoral neck, and total hip as Z-scores.

Main Outcome Measures: We assigned risk points for low energy availability (LEA), low body mass index (BMI), delayed age of menarche, oligomenorrhea, and low BMD. We calculated risk ratios for prior BSI using a Poisson regression model with robust standard errors.

Results: The mean age was 45.5. 52.8% of males and 57.9% of females scored moderate or high risk for LEA. 9% of runners had diagnosable eating disorders. 22.2% females had BMI<18.5 kg/m2. 42% females reported delayed menarche and 47% reported oligomenorrhea. 21% females and 29.3% males had “low bone mass” (Z-score≤-1.0). 3% of males had a Z-score≤-2.0. Eight females (40%) and 11 males (26.8%) reported ≥1 prior BSI. 63% and 11% females and 36% and 8% males received moderate and high cumulative risk scores. In females, BMI risk points (RR=1.72, P=.024) and higher weekly mileage (per mile per week) (RR=1.03, P=.018) were significantly associated with prior BSI. BMD risk points were associated with higher risk, but the effect was not statistically significant (RR=2.25, P=.082).

Conclusions: The majority of runners had a moderate or high cumulative risk scores indicating the severity of female or male athlete triad, which is known to have long term health repercussions including negative bone health effects. Risk factors for prior BSI in ultramarathon runners were low BMD in males and low BMI and higher weekly mileage in females.

Level of Evidence: Level III

To cite this abstract in AMA style:

Miller EK, Kraus E, Hoeg TB, Bodor M, Fredericson M, Sainani K. Identifying Risk Factors for Female Athlete Triad and a Male Equivalent in Ultramarathon Runners [abstract]. PM R. 2019; 11(S2)(suppl 2). https://pmrjabstracts.org/abstract/identifying-risk-factors-for-female-athlete-triad-and-a-male-equivalent-in-ultramarathon-runners/. Accessed June 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to AAPM&R Annual Assembly 2019

PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/identifying-risk-factors-for-female-athlete-triad-and-a-male-equivalent-in-ultramarathon-runners/

Leading the Way. Baltimore, MD & Virtual. October 20-23, 2022. #aapmr22

PM&R Journal

View issues of PM&R on the Wiley Online Library »

American Academy of Physical Medicine and Rehabilitation

Visit the official site for the American Academy of Physical Medicine and Rehabilitation »

AAPM&R Annual Assembly

Visit the official site for the AAPM&R Annual Assembly »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Wiley